Please login to the form below

Not currently logged in
Email:
Password:

Roche reduces greenhouse gas emissions ahead of schedule

Roche achieves a 10.8 per cent reduction in greenhouse gas emissions since at its US sites

Swiss-headquartered pharmaceutical company Roche has achieved a 10.8 per cent reduction in greenhouse gas (GHG) emissions since 2001 at its US sites.

The reduction is two years ahead of the goal set by Roche in support of the US Environmental Protection Administration's (EPA) Climate Leaders programme, which was launched back in 2002.

The EPA's Climate Leaders programme is a voluntary industry-government partnership to develop long-term comprehensive climate change strategies. Industry Partners set corporate-wide greenhouse gas (GHG) reduction goals and inventory their emissions regularly to measure progress.

Roche's goal was a combined 10 per cent reduction of 2001 greenhouse gas emissions by the end of 2008.

Roche has also submitted new goals scheduled to be achieved by 2010. In the next three years, Roche has pledged to further reduce greenhouse gas emissions across the country and will move from a 10 per cent goal to a 15 per cent reduction of gases by 2010.

In September 2007, Roche was awarded the first Financial Times / Citi Private Bank Environmental Award as the company with "The Greatest Improvement in Carbon Efficiency Achieved by a Large Enterprise both on a European and a Global Level."

5th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics